No headlines found.
No press releases found.
No news found.
The iShares iBonds Dec 2036 Term Corporate ETF (the "Fund") seeks to track the investment results of an index composed of U.S. dollar- denominated, investment-grade corporate bonds maturing in 2036. The Fund seeks to meet its investment objective generally by investing in component securities of the Bloomberg December 2036 Maturity Corporate Index (the "Underlying Index"). The Fund may also invest in U.S. government securities, short-term paper, cash and cash equivalents, including shares of money market funds advised by BFA or its affiliates. The Underlying Index is composed of U.S. dollar-denominated, taxable, investment-grade (as determined by Bloomberg Index Services Limited (the "Index Provider" or "Bloomberg")) corporate bonds scheduled to mature between January 1, 2036 and December 15, 2036, inclusive. As of December 31, 2025, a significant portion of the Underlying Index is represented by securities of companies in the consumer goods and services industry or sector. The Underlying Index consists of U.S. dollar-denominated, investment-grade securities publicly issued by U.S. and non-U.S. corporate issuers that have $300 million or more of outstanding face value at the time of inclusion.
iShares Ibonds Dec 2036 Term Corporate ETF trades on the ARCA stock market under the symbol IBCB.
As of July 14, 2026, IBCB stock price climbed to $24.80 with 5,322 million shares trading.
IBCB has a beta of 0.18, meaning it tends to be less sensitive to market movements. IBCB has a correlation of 0.18 to the broad based SPY ETF.
IBCB has a market cap of $78.12 million. This is considered a Micro Cap stock.
IBCB support price is $24.62 and resistance is $24.80 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IBCB shares will trade within this expected range on the day.
